CPIG
CCXI

Chicago Partners Investment Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Chicago Partners Investment Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,410
Closed -$355K – 603
2021
Q2 		$355K Buy
24,410
+15,666
+179% +$386K 0.03% 392
2021
Q1 		$414K Buy
8,744
+2,430
+38% +$146K 0.03% 331
2020
Q4 		$407K Buy
+6,314
New +$361K 0.04% 316

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Chicago Partners Investment Group's CCXI Position: Q3 2021 in Review

Chicago Partners Investment Group sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 24,410 shares — an estimated $355K sold.

Chicago Partners Investment Group first reported a position in CCXI in Q4 2020 and held it in 3 quarters. The position peaked at $414K in Q1 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Chicago Partners Investment Group reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Chicago Partners Investment Group sold 24,410 ChemoCentryx, Inc. shares in Q3 2021, an estimated $355K.
  • Chicago Partners Investment Group first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 3 quarters.
  • Chicago Partners Investment Group's ChemoCentryx, Inc. position peaked at $414K in Q1 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Chicago Partners Investment Group's 13F filing for Q3 2021, filed 12 Nov 2021.